Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12239 | 857 | 30.3 | 48% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1987 | 5071 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BOF 4272 | Author keyword | 18 | 89% | 1% | 8 |
2 | MULTIPLE INDICATOR DILUTION | Author keyword | 4 | 33% | 1% | 11 |
3 | HEPATIC ELIMINATION | Author keyword | 4 | 47% | 1% | 7 |
4 | MULTIFILT | Author keyword | 4 | 75% | 0% | 3 |
5 | SECT PHARMACOKINET | Address | 4 | 23% | 2% | 16 |
6 | LOCAL DISPOSITION | Author keyword | 3 | 100% | 0% | 3 |
7 | NARUTO DRUG METAB | Address | 3 | 100% | 0% | 3 |
8 | STATISTICAL MOMENT ANALYSIS | Author keyword | 2 | 44% | 0% | 4 |
9 | FRACTAL HETEROGENEITY | Author keyword | 2 | 67% | 0% | 2 |
10 | NARUTO | Address | 2 | 18% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BOF 4272 | 18 | 89% | 1% | 8 | Search BOF+4272 | Search BOF+4272 |
2 | MULTIPLE INDICATOR DILUTION | 4 | 33% | 1% | 11 | Search MULTIPLE+INDICATOR+DILUTION | Search MULTIPLE+INDICATOR+DILUTION |
3 | HEPATIC ELIMINATION | 4 | 47% | 1% | 7 | Search HEPATIC+ELIMINATION | Search HEPATIC+ELIMINATION |
4 | MULTIFILT | 4 | 75% | 0% | 3 | Search MULTIFILT | Search MULTIFILT |
5 | LOCAL DISPOSITION | 3 | 100% | 0% | 3 | Search LOCAL+DISPOSITION | Search LOCAL+DISPOSITION |
6 | STATISTICAL MOMENT ANALYSIS | 2 | 44% | 0% | 4 | Search STATISTICAL+MOMENT+ANALYSIS | Search STATISTICAL+MOMENT+ANALYSIS |
7 | FRACTAL HETEROGENEITY | 2 | 67% | 0% | 2 | Search FRACTAL+HETEROGENEITY | Search FRACTAL+HETEROGENEITY |
8 | 2 COMPARTMENT DISPERSION MODEL | 1 | 100% | 0% | 2 | Search 2+COMPARTMENT+DISPERSION+MODEL | Search 2+COMPARTMENT+DISPERSION+MODEL |
9 | DIFFUSIONAL BARRIER | 1 | 50% | 0% | 2 | Search DIFFUSIONAL+BARRIER | Search DIFFUSIONAL+BARRIER |
10 | ENALAPRIL AND ENALAPRILAT | 1 | 50% | 0% | 2 | Search ENALAPRIL+AND+ENALAPRILAT | Search ENALAPRIL+AND+ENALAPRILAT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MULTIPLE INDICATOR DILUTION | 55 | 70% | 5% | 45 |
2 | LOCAL DISPOSITION | 41 | 90% | 2% | 18 |
3 | 2 COMPARTMENT DISPERSION MODEL | 27 | 76% | 2% | 19 |
4 | HEPATIC ELIMINATION | 21 | 48% | 4% | 32 |
5 | GENTISAMIDE | 17 | 100% | 1% | 8 |
6 | RESIDENCE TIME DISTRIBUTIONS | 15 | 38% | 4% | 31 |
7 | CYTOPLASMIC BINDING | 11 | 69% | 1% | 9 |
8 | DIFFUSIONAL BARRIER | 9 | 50% | 2% | 13 |
9 | DISPERSION MODEL | 7 | 16% | 5% | 42 |
10 | HEPATIC DRUG ELIMINATION | 7 | 67% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Application of a convective-dispersion model to predict in vivo hepatic clearance from in vitro measurements utilizing cryopreserved human hepatocytes | 2003 | 10 | 11 | 73% |
CLEARANCE APPROACHES IN PHARMACOLOGY | 1987 | 311 | 231 | 24% |
MODELS OF HEPATIC DRUG ELIMINATION | 1992 | 26 | 19 | 74% |
Formed and preformed metabolites: facts and comparisons | 2008 | 14 | 197 | 26% |
Safety testing of metabolites: Expectations and outcomes | 2009 | 10 | 101 | 31% |
PBPK Modeling of Intestinal and Liver Enzymes and Transporters in Drug Absorption and Sequential Metabolism | 2010 | 20 | 191 | 14% |
DETERMINANTS OF METABOLITE DISPOSITION | 1992 | 13 | 84 | 62% |
Loading-washout studies of the stereoselective sinusoidal uptake of (R)and (S)-2-phenylpropionyl acyl glucuronide | 2006 | 0 | 17 | 53% |
The multiple indicator dilution method and its utility in risk assessment | 2000 | 5 | 73 | 40% |
Effect of hypoxia on cytochrome P450 activity and expression | 2004 | 48 | 133 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT PHARMACOKINET | 4 | 23% | 1.9% | 16 |
2 | NARUTO DRUG METAB | 3 | 100% | 0.4% | 3 |
3 | NARUTO | 2 | 18% | 1.1% | 9 |
4 | PLATEAU ENVIRONM DAMAGE CONTROL | 1 | 33% | 0.2% | 2 |
5 | ADV SCI TECHNOL BIOACT MAT | 1 | 50% | 0.1% | 1 |
6 | BIOPHYS PHYSICOCHEM | 1 | 50% | 0.1% | 1 |
7 | CJF 91 07 | 1 | 50% | 0.1% | 1 |
8 | PHARMACOGENET MOL TOXICOL | 1 | 50% | 0.1% | 1 |
9 | SIGNALISAT DIFFERENCIAT MACROPHAGES | 1 | 50% | 0.1% | 1 |
10 | PHYS EXPT ONCOL | 0 | 33% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000158691 | MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM |
2 | 0.0000139188 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//DISTRIBUTION CLEARANCE//CURVE MOMENTS |
3 | 0.0000136297 | INTERSPECIES SCALING//DMPK TRANSLAT SCI//WELL STIRRED MODEL |
4 | 0.0000112855 | CONGENITAL CHLORIDE DIARRHEA//SLC26A3//NASI 1 |
5 | 0.0000106670 | K M AND V MAX//PERFUSED MOUSE LIVER//N DESMETHYLDIAZEPAM |
6 | 0.0000103509 | BILITRANSLOCASE//CANALICULAR MEMBRANE//HEPATOCYTE COUPLETS |
7 | 0.0000099939 | METABOLIC ZONATION//BIVASCULAR LIVER PERFUSION//CARBAMOYLPHOSPHATE SYNTHETASE I |
8 | 0.0000082486 | MONOETHYLGLYCINEXYLIDIDE//MEGX//C 13 METHACETIN |
9 | 0.0000082227 | TRIMELAMOL//HEXAMETHYLMELAMINE//DEHYDROEMETINE |
10 | 0.0000076527 | INO 2628 CZ//DOUBLE PEAKS//DISCONTINUOUS ABSORPTION |